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Abstract 
Purpose: To investigate which factors influence time to death in hospital in critically ill patients worldwide, including 
the possible impact of gross national income (GNI).
Methods: This was a pre‑defined post hoc analysis of the Intensive Care Over Nations (ICON) database, which 
included 10,069 patients. For this sub‑analysis, we included only the 2062 60‑day in‑hospital non‑survivors (22.3 %) 
among the 9258 patients with available hospital mortality and length‑of‑stay data. We categorized these non‑survi‑
vors into three groups according to the time of death after ICU admission: early (<5 days), intermediate (6–28 days) or 
late (>28 days).
Results: Time to death in hospital was early in 1068 of the 2062 non‑survivors (52 %), intermediate in 808 (39 %), and 
late in 186 (9 %). Patients who died early had higher severity scores and were more likely to require mechanical venti‑
lation on ICU admission, whereas those who died late were more likely to be older and to have had infection on ICU 
admission or during the ICU stay. Multilevel analysis indicated a stepwise increase in the risk of late or intermediate 
deaths according to increasing GNI. Patients admitted to ICUs in countries with high or upper‑middle GNI were more 
likely to die late than those admitted to countries with low/lower‑middle GNI [odds ratio (95 % confidence interval) 
4.78 (1.94–11.76), p < 0.001, and 1.64 (1.10–2.45), p = 0.02, respectively].
Conclusions: Duration of hospital stay prior to death in critically ill patients is longer in older patients, surgical 
patients, and patients with infection. GNI is a major determinant of time to death in hospital in these patients. These 
observations may have important organizational and ethical implications.
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Introduction
Mortality rates in modern multidisciplinary intensive 
care units (ICUs) usually average 10–25  % [1, 2]. Many 
of the deaths occur soon after admission due to the high 
severity of acute illness, however a substantial number 
of patients remain in the ICU for longer periods and 
eventually develop complications leading to late mortal-
ity [3]. In most of these latter cases, death is secondary 
to multiorgan failure and is anticipated, often leading 
to the decision to withdraw or limit life support; unex-
pected deaths rarely occur in the ICU [4]. However, the 
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Take-home message: Duration of hospital stay prior to death in 
critically ill patients is longer in older patients, surgical patients, and 
patients with infection. Gross national income is a major determinant of 
time to death in these patients.
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decision-making process in end-of-life situations is com-
plex and requires the consideration of multiple factors, 
including severity of illness, physiological reserve, age, 
comorbidities, prior quality of life, and patient, family, 
and physician preferences.
Optimization of healthcare resources is a major 
concern worldwide, and in some countries efforts to 
save lives may be severely impaired due to the lack of 
resources. Financial incentives inherent in hospital pay-
ment methods may influence hospital lengths of stay 
(LOS). Maintaining the quality of care while lowering the 
associated costs is a hard sought-after goal of healthcare 
providers [5]. Two- to threefold differences in ICU risk-
adjusted mortality have been reported between centers, 
irrespective of the model that is used to adjust for sever-
ity of illness [6], and similar variations have been seen in 
risk-adjusted ICU LOS [7]. However, whether the level 
of healthcare resources in different regions of the globe 
influence the time to death due to critical illness is not 
clear.
The aim of the study reported here was to explore the 
independent factors associated with time to death in 
hospital in critically ill patients included in a large inter-
national database—the Intensive Care Over Nations 
(ICON) audit—with a special emphasis on the possible 
impact of the gross national income (GNI). We hypoth-
esized that non-survivors in high-income countries may 
have longer LOS because sophisticated life support is 
more readily available and financial resources are suf-
ficient to sustain prolonged organ support and allow for 
delays in end-of-life decision-making.
Methods
This is a pre-defined post hoc analysis of data from the 
ICON audit, which was conducted to better understand 
ICU patient demographics and ICU organization around 
the world. Full details on the methodology of this audit 
and definitions have been published elsewhere [8]. Par-
ticipation was entirely voluntary, with no financial 
incentive. The participating institutions [Electronic Sup-
plementary Material (ESM) Appendix 1] obtained ethical 
approval from their individual ethical review boards.
Each center prospectively collected data on all adult 
(>16 years) patients admitted to their ICU between 8 May 
and 18 May 2012, except for those patients who stayed in 
the ICU for <24 h for routine postoperative surveillance. 
Data were collected daily for a maximum of 28  days in 
the ICU. Data on hospital mortality were captured for up 
to 60 days.
Case report forms were electronically provided to the 
investigators using a secure internet-based website. Data 
on demographics and comorbid diseases were collected 
on admission. In this study the term surgical admissions 
refer to patients who had had surgery in the 4 weeks pre-
ceding admission to the ICU. Clinical and laboratory data 
for Simplified Acute Physiology Score II (SAPS) II [9] 
and Acute Physiologic Assessment and Chronic Health 
Evaluation (APACHE) II [10] scores were reported as the 
worst values within 24 h after admission. Microbiological 
data and clinical infections were reported daily. A daily 
evaluation of organ function according to the Sequential 
Organ Failure Assessment (SOFA) score was performed 
[11]; organ failure was defined as a SOFA score >2 for the 
organ in question.
Infection was defined according to the criteria of the 
International Sepsis Forum [12]. Sepsis was defined as 
the presence of infection with the concomitant occur-
rence of at least one acute organ failure attributed to 
infection. Septic shock was defined as sepsis associated 
with cardiovascular failure. Organ failure was judged 
not to be related to sepsis if it was already present 24 h 
before the onset of infection. ICU-acquired infection 
was defined as infection identified at least 48 h after ICU 
admission.
For the purposes of the sub-study, we included only 
non-surviving patients among those for whom hospi-
tal mortality and LOS data were available. Patients who 
remained alive in the hospital at day 60 were consid-
ered to be survivors for this analysis. We categorized 
hospital non-survivors into three groups according to 
the time to death after ICU admission in hospital: early 
(≤5  days), intermediate (6–28  days), or late (≥28  days) 
death. The cutoff for early mortality was chosen based on 
the median time of mortality in our population (5 days). 
The majority of published studies in critically ill patients 
use 28-day mortality as a primary outcome; therefore, we 
also used this cutoff to define late mortality.
For the purpose of this study, the 82 participating coun-
tries were classified into three income groups (low/lower 
middle, upper middle, and high) using the World Bank 
Atlas [13] classification of countries from 2011.
Statistical analysis
Data are shown as means with standard deviation, 
medians and interquartile ranges, or numbers and per-
centages. For continuous variables, the assumption of 
normality was checked by inspection of residual and 
normal plots. Differences between groups in terms of 
distribution of variables were assessed using analy-
sis of variance, Chi-square test, or Fisher’s exact test, as 
appropriate.
To determine the relative risk of being in the interme-
diate or late in-hospital mortality groups, we performed 
a multivariable analysis using a multilevel multino-
mial logistic model with three levels: patient, hospital, 
and country (for full details, see ESM). The dependent 
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variable was time to death in hospital categorized into 
early (reference category), intermediate, and late. The 
explanatory variables considered in the model were:
  • Patient-level factors: age, sex, SAPS II score, type 
of admission, source of admission, treatment with 
mechanical ventilation or renal replacement therapy 
(RRT) at any time during the ICU stay, comorbidities, 
presence of infection at any time during the ICU stay, 
and a decision to withhold/withdraw life-sustaining 
support at any time during the ICU stay.
  • Hospital-level factors: type of hospital, ICU specialty, 
total number of ICU patients in 2011, number of 
staffed ICU beds.
  • Country-level factors: GNI.
The results of fixed effects (measures of associa-
tion) are given as odds ratios with their 95 % confidence 
intervals. Random effects (measures of variation) meas-
ures included the variance (var). Data were analyzed 
using SPSS® Statistics software, version 22 for Windows 
(IBM Corp., Armonk, NY) and R software, version 2.0.1 
(CRAN project; R Foundation for Statistical Comput-
ing, Vienna, Austria). All reported p values are two-sided, 
and a p value of <0.05 was considered to be statistically 
significant.
Results
We studied the 2062 non-survivors (22.3  %) among the 
9258 patients for whom outcome and length of stay 
data were available. The median hospital LOS for these 
non-survivors was 5 (IQR 2–13) days after ICU admis-
sion. The demographic data of these patients are shown 
in Table  1 and the characteristics of each participating 
center are given in ESM Table e1. The mean patient age 
was 65 years, and mean SAPS II score was 57 points. An 
infection was present on ICU admission in 731 (35.5 %) 
of the non-survivors, and more than half of all non-sur-
vivors (1076, 52.2 %) had an infection at some point dur-
ing the ICU stay (Table  2). Mechanical ventilation was 
already being administered to 1411 (68  %) of the non-
survivors at ICU admission and to 1651 (80 %) at some 
point during the ICU stay (Table 2).
Of the 2062 non-survivors, 1068 (52 %) died within the 
first 5 days in the ICU, 808 (39 %) died after 6–28 days, 
and 186 (9  %) died after >28  days. Patients who died 
early had higher severity scores (SAPS II and admission 
SOFA scores) than those with intermediate or late time 
to death. Patients who died early were more likely to be 
receiving mechanical ventilation on admission than those 
with intermediate or late time to death, but they were less 
likely to receive RRT during the ICU stay. Patients who 
died early more often had neurological, cardiovascular, 
respiratory and renal failures on ICU admission and neu-
rological failure at any time during the ICU stay than 
those with intermediate or late time to death. Patients 
with intermediate or late time to death more often had 
coagulation or hepatic failure during the ICU stay than 
patients with early time to death (Table 2). A history of 
non-hematological cancer or corticosteroid adminis-
tration prior to ICU admission was more common in 
patients with intermediate or late time to death, as was 
a diagnosis of infection at any time during the ICU stay.
The proportion of patients with a late time to death 
was higher in countries with a higher GNI than in those 
with a lower GNI [10.4 % (high GNI) vs 7.7 % (interme-
diate GNI) vs 3.7  % (low/low middle GNI); p =  0.001]. 
The pattern was similar for patients with intermediate 
time to death (40.5 vs 38.7 vs 31.9, respectively; p = 0.04) 
(Table  2). Patients from high GNI countries with early 
time to death had higher SAPS II scores on ICU admis-
sion than patients from ICUs in low or upper middle GNI 
countries; patients admitted to ICUs in countries with 
high and upper middle GNI had higher SAPS II scores 
on ICU admission than patients from ICUs in low GNI 
countries; there were no differences in severity scores 
according to GNI in patients with late time to death 
(EMS Table e2).
Associations with time to death in hospital
The influence of patient, center, and country level char-
acteristics on the time to death in hospital, with early 
mortality as the reference category, is presented in ESM 
Table e3. After controlling for patient and hospital factors 
and GNI (country factor), between-hospital variations 
remained significant for late time to death (var =  0.56, 
p =  0.03); between-country variations in time to death 
were no longer present. Lower SAPS II scores and the 
presence of infection were independently associated with 
a higher risk of intermediate and late death. Presence of a 
decision to withhold/withdraw a life-sustaining measure 
was associated with a lower risk of intermediate or late 
death.
There was a stepwise increase in the risk of late death 
with increasing GNI (Fig.  1; ESM Table e3). Admission 
to an ICU in a country with a high or upper middle GNI 
was independently associated with a greater risk of late 
death than admission to a country with a low/lower mid-
dle GNI. Admission to an ICU with a high GNI was also 
independently associated with a greater risk of interme-
diate death compared to admission to a country with a 
low/lower middle GNI.
Discussion
To our knowledge, this is the first study to analyze the 
time to death in hospital for non-surviving patients 
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admitted to ICUs around the world. Our key new find-
ings relate to the impact of GNI on time to death in hos-
pital. In the initial ICON study [8], we showed a strong 
relationship between the risk of in-hospital death and 
the GNI and suggested that differences in ICU organi-
zation between centers may play an important role 
in determining risk of death. In the current study, we 
approached this issue differently. Although LOS has been 
defined as a possible quality measure in ICU survivors, 
the LOS prior to death for critically ill patients has not 
been widely explored. The GNI classification provided an 
opportunity to detect significant differences in the time 
to death in hospital in critically ill patients according to 
country income. The proportion of late deaths in hospital 
was significantly higher in patients admitted to ICUs in 
high-income countries than in those admitted to ICUs in 
low-income ones. The greater proportion of late deaths 
in countries with a high GNI may be related to longer 
stays due to the greater availability of sophisticated life-
sustaining technology and equipment in these countries. 
Prolonged ICU stay is a surrogate for advanced morbid-
ity or perioperative complications, and intensive resource 
Table 1 Differences in  patient demographic variables upon  intensive care unit admission according to  time to  death 
in hospital
Data are presented as the mean ± standard deviation (SD) or as the number of patients with the percentage in parenthesis, as appropriate
COPD chronic obstructive pulmonary disease, ICU intensive care unit, NYHA New York Heart Association, SAPS Simplified Acute Physiology Score, SOFA Sequential 
Organ Failure Assessment 
a Hospital non-survivors were categorized into three groups according to the time to death after ICU admission in hospital: early (≤5 days), intermediate (6–28 days), 
or late (≥28 days) death
b Data on age, sex, and type of admission were missing on eight, 28, and 94 patients, respectively
Variables Total study cohort 
(n = 2062)







Ageb (mean) 65.2 ± 16.7 64.3 ± 17.3 66.2 ± 16.0 65.7 ± 15.9 0.05
SAPS II score (mean) 56.6 ± 19.3 61.6 ± 20.4 51.5 ± 16.4 50.3 ± 16.1 <0.001
SOFA score at admission (mean) 9.3 ± 4.7 10.2 ± 4.8 8.4 ± 4.3 8.2 ± 4.2 <0.001
Maleb 1203 (59.1) 611 (57.9) 469 (59.1) 123 (66.5) 0.09
Type of admission to ICUb <0.001
  Surgical 511 (26.0) 222 (21.9) 221 (28.4) 68 (38.4)
  Medical 1343 (68.2) 716 (70.8) 523 (67.1) 104 (58.8)
  Trauma 97 (4.9) 62 (6.1) 30 (3.9) 5 (2.8)
  Other 17 (.9) 12 (1.2) 5 (.6) 0 (.0)
Comorbidities
  COPD 306 (14.8) 141 (13.2) 134 (16.6) 31 (16.7) 0.1
  Cancer (solid,  
non‑metastatic)
265 (12.9) 118 (11.0) 121 (15.0) 26 (14.0) 0.04
  Metastatic cancer 113 (5.5) 50 (4.7) 50 (6.2) 13 (7.0) 0.23
  Hematologic cancer 96 (4.7) 49 (4.6) 41 (5.1) 6 (3.2) 0.55
  Diabetes mellitus (insulin‑
dependent)
214 (10.4) 103 (9.6) 89 (11.0) 22 (11.8) 0.5
  Heart failure (NYHA III/IV) 303 (14.7) 167 (15.6) 115 (14.2) 21 (11.3) 0.27
  Chronic renal failure 270 (13.1) 136 (12.7) 111 (13.7) 23 (12.4) 0.78
  Human immunodeficiency 
virus infection
25 (1.2) 14 (1.3) 8 (1.0) 3 (1.6) 0.72
  Cirrhosis 132 (6.4) 71 (6.6) 52 (6.4) 9 (4.8) 0.65
  Immunosuppression 112 (5.4) 48 (4.5) 53 (6.6) 11 (5.9) 0.14
  Corticosteroid therapy 106 (5.1) 47 (4.4) 42 (5.2) 17 (9.1) 0.03
  Chemotherapy 84 (4.1) 41 (3.8) 37 (4.6) 6 (3.2) 0.6
Number of comorbidities 0.15
  None 864 (41.9) 472 (44.2) 318 (39.4) 74 (39.8)
  1 628 (30.5) 323 (30.2) 245 (30.3) 60 (32.3)
  >2 570 (27.6) 273 (25.6) 245 (30.3) 52 (28.0)
1458
use, including prolonged mechanical ventilation, may be 
required in these patients. A recent study in Australia 
and New Zealand analyzed patients with persistent criti-
cal illness and reported that such patients consumed 
more resources and had higher mortality rates than 
patients with acute critical illness [14]. In contrast, criti-
cal care facilities remain underdeveloped in resource-
limited countries, and prolonged organ support may not 
be practically feasible or financially viable. Importantly, 
we identified within-country interhospital variation in 
terms of the duration of stay in hospital before death, 
suggesting that differences in local ICU organization, 
including timing of end-of-life decisions, may also influ-
ence the time to death. Improved healthcare, preventive 
strategies, and technology on a worldwide basis, as well 
as analysis of the cost-effectiveness of these approaches, 
represent challenges for the future of intensive care and 
require further attention [15].
Patients who died late (after 28 days) were more likely 
to have been admitted to the ICU with an infection, and 
Table 2 Organ failure, complications, and gross national income in non-survivors according to time to death in hospital
Data are presented as the number of patients with the percentage in parenthesis
CNS Central nervous system, GNI gross national income, RRT renal replacement therapy
a Hospital non-survivors were categorized into three groups according to the time to death after ICU admission in hospital: early (≤5 days), intermediate (6–28 days), 
or late (≥28 days) death
b Horizontal percentages. The 82 participating countries were classified into three income groups (low/lower middle, upper middle, and high) using the World Bank 
Atlas [13] classification of countries from 2011
Variables Total study cohort 
(n = 2062)







Withdraw/withhold decision at any  
time during ICU stay
820 (39.8) 465 (43.5) 320 (39.6) 35 (18.8) <0.001
Infection at admission 731 (35.5) 334 (31.3) 311 (38.5) 86 (46.2) <0.001
ICU‑acquired infection 237 (11.5) 40 (3.7) 157 (19.4) 40 (21.5) <0.001
Infection at any time during ICU stay 1076 (52.2) 409 (38.3) 534 (66.1) 133 (71.5) <0.001
Mechanical ventilation at admission 1411 (68.4) 759 (71.1) 526 (65.1) 126 (67.7) 0.02
Mechanical ventilation at any time 1651 (80.1) 858 (80.3) 651 (80.6) 142 (76.3) 0.41
RRT at admission 199 (9.7) 113 (10.6) 65 (8.0) 21 (11.3) 0.13
RRT at any time 478 (23.2) 202 (18.9) 222 (27.5) 54 (29.0) <0.001
Type of organ failure at admission (alone or in combination)
 Cardiovascular 976 (47.3) 576 (53.9) 330 (40.8) 70 (37.6) <0.001
 Respiratory 793 (38.5) 437 (40.9) 292 (36.1) 64 (34.4) 0.05
 Coagulation 219 (10.6) 120 (11.2) 81 (10.0) 18 (9.7) 0.64
 Hepatic 249 (12.1) 121 (11.3) 105 (13.0) 23 (12.4) 0.54
 CNS 934 (45.3) 589 (55.1) 288 (35.6) 57 (30.6) <0.001
 Renal 709 (34.4) 440 (41.2) 216 (26.7) 53 (28.5) <0.001
Type of organ failure at any time (alone or in combination)
 Cardiovascular 1346 (65.3) 705 (66.0) 534 (66.1) 107 (57.5) 0.07
 Respiratory 1207 (58.5) 590 (55.2) 510 (63.1) 107 (57.5) <0.01
 Coagulation 461 (22.4) 186 (17.4) 224 (27.7) 51 (27.4) <0.001
 Hepatic 548 (26.6) 203 (19.0) 265 (32.8) 80 (43.0) <0.001
 CNS 1249 (60.6) 705 (66.0) 454 (56.2) 90 (48.4) <0.001
 Renal 1368 (66.3) 713 (66.8) 525 (65.0) 130 (69.9) 0.4
GNI categoryb <0.001
 Low/lower middle 188 (100) 121 (64.4) 60 (31.9) 7 (3.7)
 Upper middle 595 (100) 319 (53.6) 230 (38.7) 46 (7.7)
 High 1279 (100) 628 (49.1) 518 (40.5) 133 (10.4)
Deaths
 In the ICU 1557 (75.5) 989 (92.6) 512 (63.4) 56 (30.1) <0.001
 On the general floor 505 (24.5) 79 (7.4) 296 (36.6) 130 (69.9) <0.001
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presence of infection during the ICU stay was indepen-
dently associated with a higher risk of late death in hos-
pital. One possible explanation for this association of 
infection with later death is that physicians continue to 
treat such patients in the hope that the infection may be 
cured with appropriate antibiotics and/or better source 
control, leading to prolonged ICU stays and later deaths. 
Alternatively, the relationship between presence of infec-
tion and longer time to death may also simply indicate 
that if a patient stays in hospital longer, he or she is at 
higher risk of a nosocomial infection.
In the multivariable analysis, older age was significantly 
associated with a greater risk of later time to death in 
hospital. Elderly patients are more likely to be frail and 
have diminished physiological reserve than younger 
patients [16]. This makes them more vulnerable to the 
adverse neuromuscular and cognitive sequelae of criti-
cal illness and potentially reduces their ability to recover 
sufficiently to leave the hospital despite having survived 
the initial insult. It is also possible that older patients 
are more vulnerable to nosocomial infections, which are 
acquired later in the ICU stay. ICU patients are increas-
ingly elderly, and the relative contributions of age and 
comorbidities on late mortality are often difficult to 
determine. In the article reporting the initial results from 
the ICON audit, older age and severity of illness were 
strongly associated with mortality in hospital [8]. In the 
present analysis, patients from high income countries 
had higher disease severity on admission; however, these 
data did not impact on the final analysis when adjusted. 
A recent prospective study showed that patient charac-
teristics at ICU discharge, including age, were the strong-
est predictors of later hospital death [17]. In patients with 
septic shock, Daviaud et  al. [3] recently reported that 
age, malignancy, diabetes mellitus, no pathogen identifi-
cation, and initial SOFA score were independently asso-
ciated with ICU death within 3  days of ICU admission, 
whereas age, cirrhosis, no pathogen identification, and 
previous corticosteroid treatment were associated with 
ICU death at >3 days after ICU admission.
As expected, those who died early were more severely 
ill and had more severe organ failure, especially neuro-
logical, cardiovascular, respiratory, and renal, on ICU 
admission. Patients who died late more often developed 
hepatic dysfunction and coagulopathy. This finding is 
consistent with previous reports of failure of the hepatic 
and coagulation systems heralding a complicated clinical 
course, poor outcomes and higher mortality rates among 
critically ill patients [2]. Interestingly, the presence of 
different comorbid conditions was similar across the 
groups, apart from the presence of solid cancer and pre-
vious corticosteroid therapy, which were more prevalent 
in the cohort of patients with late deaths. In patients with 
septic shock, Daviaud et al. [3] also reported that previ-
ous corticosteroid administration was an independent 
predictor of late death.
In our study, surgical patients were more likely to die 
later, perhaps because in these patients major complica-
tions can occur late and decisions to forgo life support 
may be delayed. Additionally, mortality within 30 days of 
surgery is a global quality indicator and may influence the 
timing of end-of-life decision-making in these patients 
[18].
We acknowledge there are a number of limitations to 
our study. First, the registry was voluntary, and centers 
with higher academic resources may have been over-
represented. Similarly, the proportion of low income 
countries was less than that of high income countries; 
however the analyses performed, including those with 
fixed effects (varying within clusters), were conducted to 
minimize center and country bias. Second, data were col-
lected for a single period of 10 days and so do not reflect 
any influence of seasonal variation. Third, comorbidities 
were coded as categorical variables, and no information 
on the level of severity of these conditions was available. 
Fourth, we defined LOS as starting from ICU admission 
and did not take into account pre-ICU hospital stays. 
Fifth, the study was focused on ICU management, so that 
information on complications occurring after hospital 
discharge and on the regular floor after ICU discharge 
was limited. Finally, we have no information on patient, 
Fig. 1 Risk of intermediate or late death versus early death according 
to country gross national income (GNI). There is a stepwise increase 
in the risk of a longer time interval prior to death with increasing GNI. 
EM early mortality, IM intermediate mortality, LM late mortality
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physician, and family end-of-life preferences, culture, 
religion, or individual institutional or country character-
istics, all factors that can play an important role in end-
of-life decision-making processes [19].
In summary, the duration of hospital stay prior to death 
in non-surviving critically ill patients is generally longer 
in older patients, in surgical patients, and in patients with 
infection. Later deaths in hospital are also more common 
in higher income countries. These observations may have 
important organizational and ethical implications.
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